CQC’s Recent Awareness of the Human Medicines Regulations: Implications for Nurse-Led Clinics
The Care Quality Commission (CQC) is recognised as the independent regulator of health and social care in England. Historically, the CQC’s remit has centred around ensuring that providers meet fundamental standards of quality and safety.
However, only recently has the CQC begun to demonstrate a more active awareness of the Human Medicines Regulations 2012, which govern the manufacture, supply, and administration of medicines within the UK.
This newfound regulatory focus has significant implications, particularly for nurse-led clinics. Traditionally, these clinics have operated with a degree of autonomy, often relying on protocols and patient group directions (PGDs) as frameworks for the administration of medicines. The Human Medicines Regulations impose strict requirements regarding the prescribing, supply, and administration of medicinal products, meaning that clinics must now ensure their practices align closely with legislative expectations.
For nurse-led clinics, the main impact is likely to be a tightening of compliance requirements. The CQC’s enhanced scrutiny in this area means that clinics must review their standard operating procedures, ensure all staff are properly trained, and maintain robust records of medicine administration. There may also be a need to revisit the protocols under which nurses operate, ensuring they are consistent with the legal frameworks established by the Human Medicines Regulations.
Furthermore, clinics must be vigilant in their governance arrangements. The CQC’s awareness brings the risk of enforcement action should clinics fail to comply, ranging from improvement notices to prosecution. As such, nurse-led clinics must prioritise regulatory compliance, not only to maintain their registration with the CQC but also to safeguard patient safety and uphold professional standards.
This applies specifically to adrenaline and, in aesthetics clinics, to hyalase as well. CQC have now – in writing in a registration refusal – documented that they cannot register a new provider if they do not hold adrenaline in clinic as they cannot be sure you can keep that patient safe in the event of an anaphylactic event but they also cannot register a new provider if they do hold adrenaline & hyalase in clinic as that would breach of the Human Medicine Regulations 2012.
CQC are currently going through the application waiting lists, locating nurse-led clinics and requiring information from them about how they will address this issue. On 2 occasions within my knowledge, they have refused the application at that stage if the applicant cannot find a solution within a couple of weeks. As yet I have not heard of an approach that have been deemed acceptable by CQC
Other current ‘hot potatoe’ issues:
Planning permission – If you have a clinic at your home, you will be required to submit proof that you have the appropriate planning permissions and building regulation certificates in place – or confirmation from planning authority that you do not need planning permission for your structure.
If the home you use as a clinic is rented, you will still need to submit proof that the property has the appropriate planning permissions and your tenancy agreement / landlord letter which allows you to use the property for business
If you lease a commercial property, you will need to submit your lease ensuring it specifically states it has the appropriate planning permission category for your business activity.
Mortgage lender approval – If you have a mortgage / finance on the property, you will be required to submit proof that you have the mortgage lenders permission / approval for the business activity. This can be a letter or email from them.
In summary, the CQC’s growing awareness of the Human Medicines Regulations marks a pivotal shift in the regulatory landscape for nurse-led clinics. By adapting to these changes and embedding compliance into everyday practice, clinics can continue to deliver high-quality care while navigating the evolving legal environment. This proactive approach will ensure both the protection of patients and the sustainability of nurse-led services within the broader healthcare system.
